866-897-8297

Call Is Confidential & Toll Free

Myrbetriq

Myrbetriq is a beta-3 adrenergic receptor agonist for the management of overactive bladder. It is an alternative to antimuscarinic drugs for this indication. FDA approved on June 28, 2012.

Myrbetriq has little effect on the mean maximum flow rate or mean detrusor pressure at maximum flow rate in patients with lower urinary tract symptoms and bladder outlet obstruction. Furthermore, myrbetriq increases blood pressure in a dose dependent manner. However, this effect is reversible when myrbetriq is discontinued. Myrbetriq also increases heart rate in a dose dependent manner. The dose in which half-maximal efficacy is demonstrated is 25 mg. Comparatively, the dose in which maximal efficacy is demonstrated is 100 mg.

Most commonly reported adverse reactions (> 2% and > placebo) were hypertension, nasopharyngitis, urinary tract infection and headache

Imprints


Drug: Myrbetriq
Strength: 25 Mg
Pill Imprint: Logo 325
Color: Brown
Shape: Elliptical / Oval

View Images & Details

Drug: Myrbetriq
Strength: 50 Mg
Pill Imprint: Logo 355
Color: Yellow
Shape: Elliptical / Oval

View Images & Details
Disclaimer: We strive to ensure that the content on pilladdictions.com is current and factual at the time it was written. However, because new information and discoveries are always becoming available, we are not making any representations or warranties with respect to this content. Please always rely on the guidance of your physician for information about the drugs you are taking and the impacts they may or may not have on your health.

Questions About Prescription Drug Addiction?

(888) 740-2069

Questions About Prescription Drug Addiction?